Mansoor Amiji, Ph.D.
Professor and Chair, Department of Pharmaceutical Sciences, Northeastern University
Thomas Crawford, Ph.D.
Formerly with Pharmaceutical Sciences at Pfizer
Mark E. Davis, Ph.D.
Professor of Chemical Engineering, California Institute of Technology
Robert S. Kerbel, Ph.D.
Professor of Medical Biophysics, University of Toronto
Robert S. Langer, Ph.D.
Institute Professor and the Germeshausen Professor of Chemical and Biomedical Engineering, Massachusetts Institute of Technology
Lawrence Reiter, Ph.D.
Formerly with Medicinal Chemistry at Pfizer
Shiladitya Sengupta, Ph.D.
Founder, Cerulean Pharma Inc.
Assistant Professor, Harvard Medical School
Vladimir P. Torchilin, Ph.D.
Distinguished Professor of Pharmaceutical Sciences, Northeastern University
Bruce R. Zetter, Ph.D.
Professor of Cancer Biology, Department of Surgery, Harvard Medical School
Medical and Clinical Advisors
Roger Cohen, M.D.
Professor of Medicine and Associate Director of Clinical Research at the Abramson Cancer Center of the University of Pennsylvania
Carl June, M.D.
Director, Translational Research Abramson Cancer Center at University of Pennsylvania and Professor of Pathology and Laboratory Medicine
Lee Nadler, M.D.
Senior Vice President, Experimental Medicine, Dana Farber Cancer Institute and Professor of Medicine, Harvard Medical School
Marcel Rozencweig, M.D.
Senior Vice President, Clinical Affairs, Sopherion Therapeutics and Associate Adjunct Professor, Department of Medicine, NYU Langone Medical Center
Formerly Vice President, Oncology, Infectious Diseases and Immunology Clinical Research at Bristol-Myers Squibb
Daniel D. Von Hoff, M.D., F.A.C.P.
Physician in Chief, Distinguished Professor, Translational Genomics Research Institute, Professor of Medicine, Mayo Clinic and Chief Scientific Officer Scottsdale Healthcare and U.S. Oncology